During the presidency, the FAMHP will host more than 20 technical meetings and high-level events.

Meeting/Event Short description Date Location
Heads of Medicines Agencies (HMA) 1   Meeting of Heads of Medicines Agencies. 24.01.2024 – 25.01.2024 Virtual
3Rs workshop and conference Workshop and conference on 3V alternatives to animal testing in drug testing.
Presentations conference
30.01.2024 – 31.01.2024   Brussels/Antwerp
IT Directors Group A forum bringing together the IT directors of National Medicines Agencies. 21.02.2024 – 23.02.2024  Antwerp
Clinical Trials Coordination Group (CTCG)
Bringing together experts for the classification, assessment and monitoring of clinical trials. 05.03.2024 – 07.03.2024 Brussels
CEG-CAMD (Competent Authorities for Medical Devices) Created in order to improve collaboration, communication and the monitoring of medical devices across Europe. 12.03.2024 – 15.03.2024 Ghent
Committee for Orphan Medicinal Products (COMP) Committee for Evaluation and Recommendation of Medicinal Products with Orphan Drug Status intended for the Diagnosis, Prevention or Treatment of Rare Diseases.  26.03.2024 – 28.03.2024 Leuven
European medicines agencies co-operation of legal and legislative issues (EMACOLEX) Legal support from the European Medicines Regulatory Network. 03.04.2024 – 05.04.2024 Antwerp
Coordination Group for Mutual Recognition and Decentralised procedures for veterinary medicinal products (CMD-v)
Committee focusing on the efficient handling of mutual recognition procedures and decentralised market authorisations for veterinary drugs. 09.04.2024 – 11.04.2024   Ghent
Committee for Veterinary Medicinal Products (CVMP) Committee focusing on the efficient handling of mutual recognition procedures and decentralised market authorisations for veterinary drugs. 09.04.2024 – 11.04.2024   Ghent
Conference: Healthcare needs as drivers for healthcare policy and innovation The aim is to establish a research and innovation ecosystem that focuses on the most pressing health needs and not solely on pharmaceuticals. 17.04.2024 – 18.04.2024 Brussels
Joint meeting NCAPR.HTA-HAG.HMA2 A meeting of:
  • National Competent Authorities on Pricing and Reimbursement and Public Healthcare Payers.
  • Health Technology Assessment Agencies
  • Heads of Agencies Group
  • Heads of Medicines Agencies
18.04.2024 Brussels
Heads of Medicines Agencies (HMA) 2 Meeting of Heads of Medicines Agencies. 19.04.2024  Brussels
Committee on Herbal Medicinal Products (HMPC) Committee responsible for collecting and reviewing scientific data on herbal substances, preparations and combinations 23.04.2024 – 25.04.2024 Louvain-la-Neuve
Paediatric Committee (PDCO) Committee responsible for activities in the field of medicines for children and the development of such medicines. 15.05.2024 – 17.05.2024  Leuven
Committee for Advanced Therapies (CAT) Committee responsible for reviewing the quality, safety and efficacy of advanced therapy drugs. 15.05.2024 – 17.05.2024   Leuven
Working Group of Communications Professionals (WGCP) Working group established to help develop communications expertise and share good practices. 22.05.2024 – 24.05.2024 Brussels
Pharmacovigilance Risk Assessment Committee
Committee responsible for reviewing all aspects of risk management of medicinal products for human use. 27.05.2024 – 29.05.2024 La Hulpe
Working Group of Enforcement Officers (WGEO) Working group contributing to the protection of human and animal health and welfare, preventing and combating illegal trade and counterfeit drugs. 28.05.2024 – 31.05.2024  Ghent
Committee for Medicinal Products for Human Use (CHMP) Scientific committee responsible for medicinal products for human use and their authorisation. 03.06.2024 – 05.06.2024   Brussels
Scientific Advice Working Party (SAWP) Permanent working group of the CHMP, providing scientific advice and assistance on protocols. 03.06.2024 – 05.06.2024  Brussels
Coordination Group for Mutual Recognition and Decentralised Procedures - Human (CMD-h) Working group examining all issues relating to the market authorisation of medicinal products for human use in two or more Member States. 10.06.2024 – 12.06.2024 Ghent
Homeopathic Medicinal Products Working Group (HMPWG) Working group dealing with homeopathic medicines for human and veterinary use. 24.06.2024 – 26.06.2024 Bruges 
Working Group of Quality Managers (WGQM) Working group providing guidelines on quality management and the benchmarking of best practices. 26.06.2024 – 28.06.2024   Brussels



Last updated on 23/02/2024